2021-03-02

The Outcome. IRL Sweden has been granted EUR 50k from the SME Instrument, HORIZON 2020, phase 1. The Company. IRLAB aims to address the challenge

2021-04-08 · IRLAB (Nasdaq Stockholm: IRLAB A) announced today that the nomination committee has provided their proposal and motivated opinion ahead of the annual general meeting 2021. Martin Nicklasson is proposed as a new board member. IRLAB Therapeutics AB. 79 likes. IRLAB is a leading research and development company focused on illnesses in the central nervous system (CNS). IRLAB:s styrelse har beslutat att aktieägarna ska få ytterligare två möjligheter att utöva sin rösträtt vid stämman, förhandsröstning eller genom fullmakt enligt den lag som trädde ik IRLAB Therapeutics AB: IRLAB erbjuder förhandsröstning på årsstämman | Analysguiden - Analys, Börs, Bolagsfakta - användbart verktyg för investerare Irlab Therapeutics är ett svenskt forsknings- och läkemedelsbolag grundat i Göteborg under 2013. Verksamheten bedrivs via dotterbolaget Irlab Sweden.

IRLAB Therapeutics is not a large company by global standards. It has a market capitalization of kr1.4b, which means it wouldn’t have the attention of many institutional investors. Our analysis of the ownership of the company, below, shows that institutions are noticeable on the share registry. Most relevant news about IRLAB THERAPEUTICS AB (PUBL) 01/12: IRLAB THERAPEUTICS: presents application of deep learning on multidimensional C.. AQ. 01/11: IRLAB THERAPEUTICS: presents new data indicating that mesdopetam could prevent .. AQ. 2020: IRLAB Therapeutics AB. 79 likes. IRLAB is a leading research and development company focused on illnesses in the central nervous system (CNS). 2021-03-02 IRLAB Therapeutics is not a large company by global standards.

2021-04-08

År. Kommentarer. A-aktien är noterad på Nasdaq Stockholm IRLAB Therapeutics komplett bolagsfakta & börsnyheter från Analysguiden.

All news about IRLAB THERAPEUTICS AB (PUBL) 03/25: IRLAB THERAPEUTICS : drug candidate mesdopetam's mechanism of action receives c.. AQ

IRLAB is a leading research and development company focused on illnesses in the central nervous system (CNS). IRLAB Therapeutics is not a large company by global standards. It has a market capitalization of kr1.4b, which means it wouldn’t have the attention of many institutional investors. Our analysis of the ownership of the company, below, shows that institutions are noticeable on the share registry. Most relevant news about IRLAB THERAPEUTICS AB (PUBL) 01/12: IRLAB THERAPEUTICS: presents application of deep learning on multidimensional C.. AQ. 01/11: IRLAB THERAPEUTICS: presents new data indicating that mesdopetam could prevent .. AQ. 2020: IRLAB Therapeutics AB. 79 likes. IRLAB is a leading research and development company focused on illnesses in the central nervous system (CNS).

Publicerad: 2021-01-11 (Cision) IRLAB A ____ > Q3 report 2020 > Annual report 2019 > Latest presentation. IRLAB Therapeutics AB (publ) Arvid Wallgrens Backe 20. 413 46 Göteborg +46 31 757 38 00.
Psykosocial stress

413 46 Göteborg +46 31 757 38 00. 2021-04-06 Share Price & News. How has IRLAB Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events. Stable Share Price: IRLAB A is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 5% a week.

Senior Research Scientist, IRLAB Therapeutics AB Science Network - Pharma, Biotech, Medical, Healthcare, Clinical, Recruitment - News, Events & Jobs. IRLAB Therapeutics AB. IRLAB THERAPEUTICS AB. Senaste nytt. 8 fonder tog en ny position. 2020-12-31 (Innehavsrapportering).
Enkät frågor stress

IRLAB Therapeutics AB,556931-4692 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, adress mm för IRLAB Therapeutics AB

Most relevant news about IRLAB THERAPEUTICS AB (PUBL) 01/12: IRLAB THERAPEUTICS: presents application of deep learning on multidimensional C.. AQ. 01/11: IRLAB THERAPEUTICS: presents new data indicating that mesdopetam could prevent .. AQ. 2020: IRLAB Therapeutics AB. 79 likes. IRLAB is a leading research and development company focused on illnesses in the central nervous system (CNS). 2021-03-02 IRLAB Therapeutics is not a large company by global standards. It has a market capitalization of kr2.2b, which means it wouldn't have the attention of many institutional investors. Taking a look at our data on the ownership groups (below), it seems that institutions are noticeable on the share registry. IRLAB Therapeutics AB. 75 likes.

View today's stock price, news and analysis for IRLAB Therapeutics AB Series A ( IRLAB.A). Barron's also provides information on historical stock ratings, target

IRRAS Announces the recruitment of Sten Gustafsson as Director of Investor Relations. PR Newswire 22d: First European patients dosed in IRLAB's Phase IIb Stock analysis for Irlab Therapeutics AB (IRLABA:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stock analysis for Irlab Therapeutics AB (6IR) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2021-02-21 IRLAB Therapeutics AB (”IRLAB” eller “Bolaget”) (IRLAB är för närvarande listat på Nasdaq First North Premier Growth Market under kortnamnet IRLAB A) meddelade den 23 september 2020 att Nasdaq Stockholms bolagskommitté beslutat att godkänna IRLAB:s ansökan om upptagande till handel av Bolagets aktier av serie A på Nasdaq Stockholms huvudlista. IRLAB’s nomination committee proposes Martin Nicklasson as new board member and provides their proposal April 8, 2021 IRLAB (Nasdaq Stockholm: IRLAB A) announced today that the nomination committee has provided their proposal and motivated opinion ahead of the annual general meeting 2021.

tor, apr 08, 2021 16:30 CET. IRLAB (Nasdaq Stockholm: Aktieägarna i IRLAB Therapeutics AB, org.nr 556931-4692 (”IRLAB” eller ”Bolaget”), kallas härmed. IRLAB Therapeutics AB. 79 likes · 1 talking about this. IRLAB is a leading research and development company focused on illnesses in the news.cision.com. ‏‏٧٨‏ تسجيل إعجاب · يتحدث ‏١‏ عن هذا‏. ‏‎IRLAB is a leading research and development company focused on illnesses in the news.cision.com.